Authors: Spooner, RA Maycroft, KA Paterson, H Friedlos, F Springer, CJ Marais, R

Citation: Ra. Spooner et al., Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapy, INT J CANC, 93(1), 2001, pp. 123-130

Authors: Stribbling, SM Friedlos, F Martin, J Davies, L Spooner, RA Marais, R Springer, CJ

Citation: Sm. Stribbling et al., Regressions of established breast carcinoma xenografts by carboxypeptidaseG2 suicide gene therapy and the prodrug CMDA are due to a bystander effect, HUM GENE TH, 11(2), 2000, pp. 285-292

Authors: Spooner, RA Martin, J Friedlos, F Marais, R Springer, CJ

Citation: Ra. Spooner et al., In suicide gene therapy, the site of subcellular localization of the activating enzyme is more important than the rate at which it activates prodrug, CANC GENE T, 7(10), 2000, pp. 1348-1356

Authors: Niculescu-Duvaz, I Friedlos, F Niculescu-Duvaz, D Davies, L Springer, CJ

Citation: I. Niculescu-duvaz et al., Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT), ANTI-CAN DR, 14(6), 1999, pp. 517-538

Authors: Niculescu-Duvaz, I Niculescu-Duvaz, D Friedlos, F Spooner, R Martin, J Marais, R Springer, CJ

Citation: I. Niculescu-duvaz et al., Self-immolative anthracycline prodrugs for suicide gene therapy, J MED CHEM, 42(13), 1999, pp. 2485-2489

Authors: Niculescu-Duvaz, D Niculescu-Duvaz, I Friedlos, F Martin, J Spooner, R Davies, L Marais, R Springer, CJ

Citation: D. Niculescu-duvaz et al., Self-immolative nitrogen mustard prodrugs for suicide gene therapy, J MED CHEM, 41(26), 1998, pp. 5297-5309